Advertisement
Screener

PHARMOS CORP Stock-Based Compensation

PHARMOS CORP Stock-Based Compensation

PHARMOS CORP reported Stock-Based Compensation of $104.75 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2012-11-19

  • PHARMOS CORP share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $36.41K, a 17.14% decline year-over-year.
  • PHARMOS CORP share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $31.98K, a 16.61% decline year-over-year.
  • PHARMOS CORP share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $36.36K, a 8.67% decline year-over-year.
  • PHARMOS CORP share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $37.34K, a 14.03% decline year-over-year.
  • PHARMOS CORP share-based payment arrangement, noncash expense for fiscal 2011 was $159.44K, a 18.04% decline from fiscal 2010.
  • PHARMOS CORP share-based payment arrangement, noncash expense for fiscal 2010 was $194.53K.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2012-09-30$36.41K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19
$68.39K
derived: sum of 2 quarters · filed 2012-11-19
$104.75K
10-Q · filed 2012-11-19
$142.09K
derived: sum of 4 quarters · filed 2012-11-19
2012-06-30$31.98K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30
$68.34K
10-Q · filed 2012-07-30
$105.68K
derived: sum of 3 quarters · filed 2012-07-30
$149.62K
derived: sum of 4 quarters · filed 2012-11-19
2012-03-31$36.36K
10-Q · filed 2012-04-16
$73.70K
derived: sum of 2 quarters · filed 2012-04-16
$117.64K
derived: sum of 3 quarters · filed 2012-11-19
$155.99K
derived: sum of 4 quarters · filed 2012-11-19
2011-12-31$37.34K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-02-21
$81.28K
derived: sum of 2 quarters · filed 2012-11-19
$119.63K
derived: sum of 3 quarters · filed 2012-11-19
$159.44K
10-K/A · filed 2012-02-21
2011-09-30$43.93K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19
$82.29K
derived: sum of 2 quarters · filed 2012-11-19
$122.10K
10-Q · filed 2012-11-19
$165.54K
derived: sum of 4 quarters · filed 2012-11-19
2011-06-30$38.35K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30
$78.17K
10-Q · filed 2012-07-30
$121.60K
derived: sum of 3 quarters · filed 2012-07-30
$181.43K
derived: sum of 4 quarters · filed 2012-07-30
2011-03-31$39.81K
10-Q · filed 2012-04-16
$83.25K
derived: sum of 2 quarters · filed 2012-04-16
$143.08K
derived: sum of 3 quarters · filed 2012-04-16
2010-12-31$43.44K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-02-21
$103.27K
derived: sum of 2 quarters · filed 2012-02-21
$194.53K
10-K/A · filed 2012-02-21
2010-09-30$59.83K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31
$151.10K
10-Q · filed 2011-10-31
2010-06-30$91.27K
10-Q · filed 2011-08-08